HCS Pharma is selected for the co-innovation program France-Singapore 2022 of BPI France and Hello Tomorrow

We are very please to annonce our selection in the “CO-INNO INTERNATIONAL” program. Jointly organised by BPI France and Hello Tomorrow, the CO-INNO program accelerates and supports the most cutting-edge French startups from the discovery of the Singaporean ecosystem to the establishment of technological partnerships, funding and even their settlement Read more…

Development of HCS Pharma in Taïwan with an incubation process in the famous NHRI

We are really pleased to announce that we have officially created a representative office in Taïwan (company 仿生培養技術中心 ID number 90729614) which is directed by our partner, Joseph Chou 周肇隆 ジョーゼフ・チョウ, member of our advisory board. Thanks to Joseph and Professor Szecheng J. Lo, member of our scientific advisory board, all Read more…